Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans

Experimental Neurology

Volumn 208, Issue 2, 2007, Pages 185-192

  Uryu, Kunihiro ^a   Chen, Xiao Han ^b   Martinez, Dan ^a   Browne, Kevin D ^b   Johnson, Victoria E ^b   Graham, David I ^c   Lee, Virginia M Y ^a   Trojanowski, John Q ^a,b   Smith, Douglas H ^b  

^a Center for Neurodegenerative Disease Research   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Academic Development Unit   (United Kingdom)

Author keywords

Synuclein; Amyloid ; APP; Axonal injury; BACE; PS 1; Tau; TBI; Traumatic brain injury

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; NEUROFILAMENT PROTEIN; PRESENILIN 1; TAU PROTEIN;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AXONAL INJURY; BRAIN TISSUE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTRACRANIAL PRESSURE; MALE; NERVE FIBER; PERIKARYON; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; RISK ASSESSMENT; SYNUCLEINOPATHY; TRAUMATIC BRAIN INJURY; VARICOSIS;

ADOLESCENT; ADULT; AGED; AXONS; BRAIN; BRAIN INJURIES; CADAVER; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; TISSUE DISTRIBUTION;

EID: 36049047066     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.06.018     Document Type: Article

References (71)

1. Abrahamson E.E., Ikonomovic M.D., Ciallella J.R., Hope C.E., Paljug W.R., Isanski B.A., Flood D.G., Clark R.S., and DeKosky S.T. Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome. Exp. Neurol. 197 2 (2006) 437-450
2. Adams J.H., and Graham D.I. The relationship between ventricular fluid pressure and the neuropathology of raised intracranial pressure. Neuropathol. Appl. Neurobiol. 2 (1976) 323-332
3. Adams J.H., Graham D.I., Scott G., Parker L.S., and Doyle D. Brain damage in fatal non-missile head injury. J. Clin. Pathol. 33 12 (1980) 132-145
4. Adams J.H., Graham D.I., Murray L.S., and Scott G. Diffuse axonal injury due to nonmissile head injury in humans: an analysis of 45 cases. Ann. Neurol. 12 6 (1982) 557-563
5. Adams J.H., Doyle D., Ford I., Gennarelli T.A., Graham D.I., and McLellan D.R. Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology 15 1 (1989) 49-59
6. Adams J.H., Graham D.I., Gennarelli T.A., and Maxwell W.L. Diffuse axonal injury in non-missile head injury. J. Neurol. Neurosurg. Psychiatry 54 6 (1991) 481-483
7. Ben-Shlomo Y. The epidemiology of Parkinson's disease. Bailliere's Clin. Neurol. 6 1 (1997) 55-68
8. Black M., and Graham D.I. Sudden unexplained death in adults caused by intracranial pathology. J. Clin. Pathol. 55 1 (2002) 44-50
9. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl) 82 4 (1991) 239-259
10. Brendza R.P., Bacskai B.J., Cirrito J.R., Simmons K.A., Skoch J.M., Klunk W.E., Mathis C.A., Bales K.R., Paul S.M., Hyman B.T., and Holtzman D.M. Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J. Clin. Invest. 115 2 (2005) 428-433
11. Chen X.H., Siman R., Iwata A., Meaney D.F., Trojanowski J.Q., and Smith D.H. Long-term accumulation of amyloid-beta, beta-secretase, presenilin-1, and caspase-3 in damaged axons following brain trauma. Am. J. Pathol. 165 2 (2004) 357-371
12. Christman C.W., Grady M.S., Walker S.A., Holloway K.L., and Povlishock J.T. Ultrastructural studies of diffuse axonal injury in humans. J. Neurotrauma 11 2 (1994) 173-186
13. De Strooper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., Von Figura K., and Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391 6665 (1998) 387-930
14. Duda J.E., Giasson B.I., Mabon M.E., Lee V.M., and Trojanowski J.Q. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann. Neurol. 52 2 (2002) 205-210
15. Esler W.P., and Wolfe M.S. A portrait of Alzheimer secretases-new features and familiar faces. Science 293 5534 (2001) 1449-1454
16. Factor S.A., and Weiner W.J. Prior history of head trauma in Parkinson's disease. Mov. Disord. 6 3 (1991) 225-229
17. Forman M.S., Trojanowski J.Q., and Lee V.M. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 10 10 (2004) 1055-1063
18. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., Shen J., Takio K., and Iwatsubo T. Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4 2 (2002) 160-164
19. Geddes J.F., Whitwell H.L., and Graham D.I. Traumatic axonal injury: practical issues for diagnosis in medicolegal cases. Neuropathol. Appl. Neurobiol. 26 2 (2000) 105-116
20. Gennarelli T.A. Mechanisms of brain injury. J. Emerg. Med. 11 Suppl 1 (1993) 5-11
21. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., and Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290 5493 (2000) 985-989
22. Goldman S.M., Tanner C.M., Oakes D., Bhudhikanok G.S., Gupta A., and Langston J.W. Head injury and Parkinson's disease risk in twins. Ann. Neurol. 60 1 (2006) 65-72
23. Gorrie C., Oakes S., Duflou J., Blumbergs P., and Waite P.M. Axonal injury in children after motor vehicle crashes: extent, distribution, and size of axonal swellings using beta-APP immunohistochemistry. J. Neurotrauma 19 10 (2002) 1171-1182
24. Grady M.S., McLaughlin M.R., Christman C.W., Valadka A.B., Fligner C.L., and Povlishock J.T. The use of antibodies targeted against the neurofilament subunits for the detection of diffuse axonal injury in humans. J. Neuropathol. Exp. Neurol. 52 2 (1993) 143-152
25. Graham D.I., Ford I., Adams J.H., Doyle D., Teasdale G.M., Lawrence A.E., and McLellan D.R. Ischaemic brain damage is still common in fatal non-missile head injury. J. Neurol. Neurosurg. Psychiatry 52 3 (1989) 346-350
26. Graham D.I., Gentleman S.M., Lynch A., and Roberts G.W. Distribution of beta-amyloid protein in the brain following severe head injury. Neuropathol. Appl. Neurobiol. 21 1 (1995) 27-34
27. Guo Z., Cupples L.A., Kurz A., Auerbach S.H., Volicer L., Chui H., Green R.C., Sadovnick A.D., Duara R., DeCarli C., Johnson K., Go R.C., Growdon J.H., Haines J.L., Kukull W.A., and Farrer L.A. Head injury and the risk of AD in the MIRAGE study. Neurology 54 6 (2000) 1316-1323
28. Ikonomovic M.D., Uryu K., Abrahamson E.E., Ciallella J.R., Trojanowski J.Q., Lee V.M., Clark R.S., Marion D.W., Wisniewski S.R., and DeKosky S.T. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury. Exp. Neurol. 190 1 (2004) 192-203
29. Iwata A., Chen X.H., McIntosh T.K., Browne K.D., and Smith D.H. Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes. Neuropathol. Exp. Neurol. 61 12 (2002) 1056-1068
30. Kamal A., Stokin G.B., Yang Z., Xia C.H., and Goldstein L.S. Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28 2 (2000) 449-459
31. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., and Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414 6864 (2001) 643-648
32. Lambri M., Djurovic V., Kibble M., Cairns N., and Al-Sarraj S. Specificity and sensitivity of betaAPP in head injury. Clin. Neuropathol. 20 6 (2001) 263-271
33. Lazarov O., Morfini G.A., Lee E.B., Farah M.H., Szodorai A., DeBoer S.R., Koliatsos V.E., Kins S., Lee V.M., Wong P.C., Price D.L., Brady S.T., and Sisodia S.S. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J. Neurosci. 25 9 (2005) 2386-2395
34. Lees A.J. Trauma and Parkinson disease. Rev. Neurol. (Paris) 153 10 (1997) 541-546
35. Lye T.C., and Shores E.A. Traumatic brain injury as a risk factor for Alzheimer's disease: a review. Neuropsychol. Rev. 10 2 (2000) 115-129
36. Maxwell W.L., Povlishock J.T., and Graham D.L. A mechanistic analysis of nondisruptive axonal injury: a review. J. Neurotrauma 14 7 (1997) 419-440
37. Mirra S.S., Hart M.N., and Terry R.D. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch. Pathol. Lab. Med. 117 2 (1993) 132-144
38. Mortimer J.A., French L.R., Hutton J.T., and Schuman L.M. Head injury as a risk factor for Alzheimer's disease. Neurology 35 2 (1985) 264-267
39. Nashef L. Unexpected death in epilepsy: terminology and definitions. Epilepsia 38 Suppl. 11 (1997) S6-S8
40. Nayernouri T. Posttraumatic parkinsonism. Surg. Neurol. 24 3 (1985) 263-264
41. Nemetz P.N., Leibson C., Naessens J.M., Beard M., Kokmen E., Annegers J.F., and Kurland L.T. Traumatic brain injury and time to onset of Alzheimer's disease: a population-based study. Am. J. Epidemiol. 149 1 (1999) 32-40
42. Newell K.L., Boyer P., Gomez-Tortosa E., Hobbs W., Hedley-Whyte E.T., Vonsattel J.P., and Hyman B.T. Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury. J. Neuropathol. Exp. Neurol. 58 12 (1999) 1263-1268
43. Newman S.J., Gentleman S.M., Graham D.I., Brown F., and Roberts G.W. Tissue distribution and cellular localization of hyperphosphorylated tau in human head injury and age-marched controls. In: Iqbal K., Mortimer J.A., Winblad B., and Wisniewski H.M. (Eds) (1995), John Wiley & Sons, Chichester 397-403
44. Norris E.H., Giasson B.I., and Lee V.M. Alpha-synuclein: normal function and role in neurodegenerative diseases. Curr. Top. Dev. Biol. 60 (2004) 17-54
45. Nunan J., and Small D.H. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483 1 (2000) 6-10
46. Otsuka N., Tomonaga M., and Ikeda K. Rapid appearance of beta-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res. 568 1-2 (1991) 335-338
47. Pilz P. Axonal injury in head injury. Acta neurochir., Suppl. (Wien) 32 (1983) 119-123
48. Plassman B.L., Havlik R.J., Steffens D.C., Helms M.J., Newman T.N., Drosdick D., Phillips C., Gau B.A., Welsh-Bohmer K.A., Burke J.R., Guralnik J.M., and Breitner J.C. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55 8 (2000) 1158-1166
49. Povlishock J.T., and Becker D.P. Fate of reactive axonal swellings induced by head injury. Lab. Invest. 52 5 (1985) 540-552
50. Rasmusson D.X., Brandt J., Martin D.B., and Folstein M.F. Head injury as a risk factor in Alzheimer's disease. Brain Inj. 9 3 (1995) 213-219
51. Reichard R.R., White III C.L., Hladik C.L., and Dolinak D. Beta-amyloid precursor protein staining of nonaccidental central nervous system injury in pediatric autopsies. J. Neurotrauma 20 4 (2003) 347-355
52. Roberts G.W., Gentleman S.M., Lynch A., Murray L., Landon M., and Graham D.I. Beta amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 57 4 (1994) 419-425
53. Schmidt M.L., Zhukareva V., Newell K.L., Lee V.M., and Trojanowski J.Q. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease. Acta Neuropathol. (Berl) 101 5 (2001) 518-524
54. Schofield P.W., Tang M., Marder K., Bell K., Dooneief G., Chun M., Sano M., Stern Y., and Mayeux R. Alzheimer's disease after remote head injury: an incidence study. J. Neurol. Neurosurg. Psychiatry 62 2 (1997) 119-124
55. Schonheit B., Zarski R., and Ohm T.G. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol. Aging 25 6 (2004) 697-711
56. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 2 (2001) 741-766
57. Selkoe D.J., and Wolfe M.S. In search of gamma-secretase: presenilin at the cutting edge. Proc. Natl. Acad. Sci. U. S. A. 97 11 (2000) 5690-5692
58. Sherriff F.E., Bridges L.R., and Sivaloganathan S. Early detection of axonal injury after human head trauma using immunocytochemistry for beta-amyloid precursor protein. Acta Neuropathol. (Berl) 87 1 (1994) 55-62
59. Smith D.H., and Meaney D.F. Axonal damage in traumatic brain injury. Neuroscientist 6 (2000) 483-495
60. Smith D.H., Chen X.H., Nonaka M., Trojanowski J.Q., Lee V.M., Saatman K.E., Leoni M.J., Xu B.N., Wolf J.A., and Meaney D.F. Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J. Neuropathol. Exp. Neurol. 58 9 (1999) 982-992
61. Smith C., Graham D.I., Murray L.S., and Nicoll J.A. Tau immunohistochemistry in acute brain injury. Neuropathol. Appl. Neurobiol. 29 5 (2003) 496-502
62. Smith D.H., Chen X.H., Iwata A., and Graham D.I. Amyloid beta accumulation in axons after traumatic brain injury in humans. J. Neurosurg. 98 5 (2003) 1072-1077
63. Smith D.H., Uryu K., Saatman K.E., Trojanowski J.Q., and McIntosh T.K. Protein accumulation in traumatic brain injury. Neuromolecular. Med. 4 1-2 (2003) 59-72
64. Stern M.B. Head trauma as a risk factor for Parkinson's disease. Mov. Disord. 6 2 (1991) 95-97
65. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., and Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307 5713 (2005) 1282-1288
66. Stone J.R., Okonkwo D.O., Singleton R.H., Mutlu L.K., Helm G.A., and Povlishock J.T. Caspase-3-mediated cleavage of amyloid precursor protein and formation of amyloid Beta peptide in traumatic axonal injury. J. Neurotrauma 19 5 (2002) 601-614
67. Trojanowski J.Q., and Lee V.M. Parkinson's disease and related synucleinopathies are a new class of nervous system amyloidoses. Neurotoxicology 23 4-5 (2002) 457-460
68. Uryu K., Giasson B.I., Longhi L., Martinez D., Murray I., Conte V., Nakamura M., Saatman K., Talbot K., Horiguchi T., McIntosh T., Lee V.M., and Trojanowski J.Q. Age-dependent synuclein pathology following traumatic brain injury in mice. Exp. Neurol. 184 1 (2003) 214-224
69. Van Hoesen G.W., and Hyman B.T. Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog. Brain Res. 83 (1990) 445-457
70. Vassar R., Bennett B.D., Babu-Khan S., Kahn S., Mendiaz E.A., Denis P., Teplow D.B., Ross S., Amarante P., Loeloff R., Luo Y., Fisher S., Fuller J., Edenson S., Lile J., Jarosinski M.A., Biere A.L., Curran E., Burgess T., Louis J.C., Collins F., Treanor J., Rogers G., and Citron M. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286 5440 (1999) 735-741
71. Zemlan F.P., Rosenberg W.S., Luebbe P.A., Campbell T.A., Dean G.E., Weiner N.E., Cohen J.A., Rudick R.A., and Woo D. Quantification of axonal damage in traumatic brain injury: affinity purification and characterization of cerebrospinal fluid tau proteins. J. Neurochem. 72 2 (1999) 741-750